UHPLC- Instrument Influences on Maximizing Separation Performance
This Monday afternoon session will be presided over by Jason Anspach of Phenomenex (Torrance, California), who also arranged the session with Todd Maloney of Eli Lilly and Company (Indianapolis, Indiana).
Session 510, Room 409
2:00 p.m.
This Monday afternoon session will be presided over by Jason Anspach of Phenomenex (Torrance, California), who also arranged the session with Todd Maloney of Eli Lilly and Company (Indianapolis, Indiana). This session is one of John Dolan’s recommendations and is definitely one to add to your agenda.
The session will begin with opening remarks from Anspach and continue with a presentation from Xiaoli Wang of Agilent Technologies. Wang's presentation will focus on new column technologies for better and faster separations in UHPLC.
A presentation by Kenneth Joseph Fountain of Waters Corporation will follow Wang. This presentation will discuss performance and selectivity options for HPLC and UPLC separations. Next will be the presentation from the session organizer, Jason Anspach. His talk will be about UHPLC separations without system limitation.
After a 15 minute recess, the session will pick back up with Gregory K. Webster's (Abbott Laboratories) presentation titled, "Scaling UHPLC Methods to an LC Format to Enable Method Transfer: Is this a Feasible Strategy for Pharmaceutical Analyses?"
The last presentation in this session will be given by the other session organizer, Todd Maloney. His presentation is titled: Bridging the Gap Between HPLC and UHPLC — Standardizing Column Geometry and Simplifying Method Development Strategies for Pharmaceutical Analysis. The session will conclude with a brief group discussion and question/answer period.
